Pacemaker Treatment for Hypertrophic Obstructive Cardiomyopathy: Are Long-Term Results as Good as Short-Term Ones?

  • L. J. Kappenberger
  • N. Aebischer
  • X. Jeanrenaud
Conference paper


Hypertrophic cardiomyopathy (HCM) is a complex disease of multiple genetic origins. It is usually a familial cardiac disorder, recognised to be of heterogeneous expression with diverse clinical manifestations and outcome. This structural and functional abnormality of the myocardium is the phenotype of many genetic disorders of encoding proteins of the sarcomere. The diagnostic disorder is a thickened and non-dilated left ventricle in the absence of an associated condition that could explain the hypertrophy.


Hypertrophic Cardiomyopathy Hypertrophic Obstructive Cardiomyopathy Crossover Phase Longterm Result Gradient Reduction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophie cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 316:780–789,844-852PubMedCrossRefGoogle Scholar
  2. 2.
    Wigle ED, Sasson Z, Henderson MA et al (1985) Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy: a review. Progr Cardiovasc Dis 28:1–83CrossRefGoogle Scholar
  3. 3.
    Maron B, Gardin J, Flack J, Gidding S, Bild D (1995) Assessment of the prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation 92:785–789PubMedCrossRefGoogle Scholar
  4. 4.
    Maron BJ, Wolfson JK, Epstein SE, Roberts WC (1986) Intramural «small vessel» coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 8:545–557PubMedCrossRefGoogle Scholar
  5. 5.
    Posma J, Blanksma P, Van der Wall E, Vaalburg W, Crijns H, Lie K (1996) Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy. Heart 76:358–362PubMedCrossRefGoogle Scholar
  6. 6.
    Frenneaux MP, Counihan PJ, Caforio ALP, Chimakori T, McKenna WJ (1990) Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 82:1995–2002PubMedCrossRefGoogle Scholar
  7. 7.
    McKenna W, Camm J (1989) Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk. Circulation 80:1489–1492Google Scholar
  8. 8.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529–1536PubMedCrossRefGoogle Scholar
  9. 9.
    Fananapazir L, Chang A, Epstein S, McAreavy D (1992) Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiologic findings. Circulation 85:2149–2161PubMedCrossRefGoogle Scholar
  10. 10.
    Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J Jr (1964) Effects of beta-adrenergic blockade on the circulation, with particular references to observations in patients with hypertrophic subaortic stenosis. Circulation 29:84–98PubMedCrossRefGoogle Scholar
  11. 11.
    Hopf R, Kaltenbach M (1987) 10-year results and survival of patients hypertrophic cardiomyopathy treated with calcium-antagonists. Z Kardiol 76[Suppl 3]:137–144PubMedGoogle Scholar
  12. 12.
    Sherrid M, Delia E, Dwyer ED (1988) Oral disopyramid therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 62:1085–1088PubMedCrossRefGoogle Scholar
  13. 13.
    Ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst S, Vermeulen FEE, Jaarsma W (1994) Hypertrophic obstructive cardiomyopathy: initial results and long-term follow up after narrow septal myectomy. Circulation 90:1781–1785PubMedCrossRefGoogle Scholar
  14. 14.
    Seiler C, Hess OM, Schoenbeck M et al (1991) Long-term follow up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 17:634–642PubMedCrossRefGoogle Scholar
  15. 15.
    Sigwart U (1995) Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211–213PubMedCrossRefGoogle Scholar
  16. 16.
    Hassenstein P, Wolter HH (1967) Therapeutische Beherrschung einer bedrohlichen Situation bei der idiopathischen hypertrophischen Subaortenstenose. Verh Dtsch Ges Kreisl 33:242–246Google Scholar
  17. 17.
    Page A, Boudaut R, Bemurat M, Clementy J, Levy S, Besse P (1979) Importance of sequential atrioventricular pacing in obstructive myocardiopathy with atrioventricular block. Arch Mal Coeur 72:1253–1258PubMedGoogle Scholar
  18. 18.
    Jeanrenaud X, Goy JJ, Kappenberger L (1992) Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339:1318–1323PubMedCrossRefGoogle Scholar
  19. 19.
    Fananapazir L, Epstein ND, Curiel RV et al (1994) Longterm results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90:2731–2742Google Scholar
  20. 20.
    Prinzen FW, Augustijn CH, Arts T, Allessi MA, Reneman RS (1990) Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol 258:H300–H308Google Scholar
  21. 21.
    Kappenberger L, Grobéty M , Jeanrenaud X (1998) The features of a paced heart beat. In: Vardas PE (ed) Cardiac arrhythmias, pacing and electrophysiology. Kluwer, UK, pp 331–336CrossRefGoogle Scholar
  22. 22.
    Kappenberger L, Linde C, Daubert C, McKenna W, Meisel E, Sadoul N, Chojinowska L, Guize L, Gras D, Jeanrenaud X, Ryden L (1997) Pacing in hypertrophic obstructive cardiomyopathy, the PIC trial. Eur Heart J 21:1249–1256CrossRefGoogle Scholar
  23. 23.
    Undén A, Schenck-Gustavsson K, Axelson P (1993) Positive effects of increased nurse support for male patients after acute myocardial infarction. Qual Life Res 2:121–127PubMedCrossRefGoogle Scholar
  24. 24.
    Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Ryden L (1997) Longterm effects of pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest. Eur Heart J 18:636–642PubMedCrossRefGoogle Scholar
  25. 25.
    Kappenberger LJ, Linde C, Jeanreanud X, Daubert C, McKenna W, Meisel E, Sadoul N, Chojnowska L, Guize L, Gras D, Aebischer N, Gadler F, Rydén L, and the Pacing in Cardiomyopathy (PIC) Study Group (1999) Clinical progress after randomized on/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Europace 1999; 1:77–84CrossRefGoogle Scholar
  26. 26.
    Nishimura RA, Trusty JM, Hayes DL et al (1997) Dual-chamber pacing for patients with hypertrophic cardiomyopathy: a prospective randomized double-blind crossover trial (abstract). J Am Coll Cardiol 29:435–441PubMedCrossRefGoogle Scholar
  27. 27.
    Maron B, Nishimura R, McKenna W (1999) The M-Pathy study investigators assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. Circulation 99:2927–2933PubMedCrossRefGoogle Scholar
  28. 28.
    Wigle ED, Rakowsky H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy, clinical spectrum and treatment. Circulation 92:1680–1692PubMedCrossRefGoogle Scholar
  29. 29.
    Knight C, Kurbaan A, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U (1997) Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 95:2075–2081PubMedCrossRefGoogle Scholar
  30. 30.
    Prinzen FW, Augustijn CH, Allessie MA et al (1992) The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J 13:535–543PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2000

Authors and Affiliations

  • L. J. Kappenberger
    • 1
  • N. Aebischer
    • 1
  • X. Jeanrenaud
    • 1
  1. 1.Division of CardiologyCentre Hospitalier Universitaire Vaudois (CHUV)LausanneSwitzerland

Personalised recommendations